AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsTechnology, Industry, AgricultureInformation ScienceHealth CareGeographicals
Influenza, HumanInfluenza A virusInfluenza A Virus, H1N1 SubtypeInfluenza VaccinesInfluenza A Virus, H5N1 SubtypeInfluenza in BirdsInfluenza A Virus, H3N2 SubtypeHemagglutinin Glycoproteins, Influenza VirusInfluenza B virusOrthomyxoviridae InfectionsInfluenza A Virus, H9N2 SubtypeOrthomyxoviridaeInfluenza A Virus, H7N9 SubtypeHemagglutinins, ViralBirdsVaccinia virusHemagglutination Inhibition TestsNeuraminidaseVirus ReplicationReceptors, VirusRNA VirusesAntibodies, ViralPandemicsDisease OutbreaksInfluenza A Virus, H3N8 SubtypeInfluenza A Virus, H7N7 SubtypeVirus SheddingVirus CultivationInfluenza A Virus, H7N1 SubtypeInfluenza A Virus, H2N2 SubtypeAntigens, ViralViral ProteinsInfluenza A Virus, H5N2 SubtypeMolecular Sequence DataPhylogenyVirus DiseasesCell LineAntiviral AgentsOseltamivirRNA, ViralChickensGenes, ViralVirus AssemblyInfluenza A Virus, H1N2 SubtypeSimian virus 40DogsDefective VirusesSeasonsPlant VirusesDNA VirusesVaccinationAmino Acid SequenceSindbis VirusMeasles virusDucksReassortant VirusesRabies virusVaccines, InactivatedRespiratory Syncytial VirusesChick EmbryoMadin Darby Canine Kidney CellsFerretsAmantadineHepatitis B virusPoultryNeutralization TestsWest Nile virusVesicular stomatitis Indiana virusCercopithecus aethiopsVirus ActivationVero CellsVirionViral Plaque AssayInfluenza A Virus, H7N3 SubtypeVaccines, AttenuatedZanamivirMice, Inbred BALB CInfluenzavirus CVirus AttachmentVirus LatencySequence Analysis, DNAParainfluenza Virus 1, HumanCross ReactionsVirologyNucleoproteinsViral Core ProteinsVirus InactivationPneumonia, ViralCross ProtectionDNA, ViralSimian immunodeficiency virusVirulenceOncogenic VirusesRNA ReplicaseDrug Resistance, ViralMumps virusReverse Transcriptase Polymerase Chain ReactionSemliki forest virusGene Expression Regulation, ViralRespiratory Syncytial Virus Infections

Topology of viral evolution. (41/65)

 (+info)

Human infection with avian influenza A(H7N9) virus re-emerges in China in winter 2013. (42/65)

Through a national surveillance system for unexplained pneumonia, a severe case of influenza A(H7N9) in a man in his mid-30s was identified in Zhejiang Province, China on 14 October 2013. Epidemiological and clinical findings were consistent with the patterns reported during the outbreak in spring 2013, and laboratory findings showed that the virus had 99.6% identity with earlier H7N9 viruses identified in humans in the spring except for five mutations in the NA gene.  (+info)

Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013. (43/65)

 (+info)

Full genome of influenza A (H7N9) virus derived by direct sequencing without culture. (44/65)

 (+info)

Mild illness in avian influenza A(H7N9) virus-infected poultry worker, Huzhou, China, April 2013. (45/65)

 (+info)

Novel H7N9 influenza virus shows low infectious dose, high growth rate, and efficient contact transmission in the guinea pig model. (46/65)

 (+info)

Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus. (47/65)

 (+info)

One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge. (48/65)

 (+info)